CoChat

An Immunoassay to Rapidly Measure Acetaminophen Protein Adducts Accurately Identifies Patients With Acute Liver Injury or Failure

Open access
Roberts, Dean W., Lee, William M., Hinson, Jack A., Bai, Shasha, Swearingen, Christopher J., Stravitz, R. Todd, Reuben, Adrian, Letzig, Lynda, Simpson, Pippa M., Rule, Jody, Fontana, Robert J., Ganger, Daniel, Reddy, K. Rajender, Liou, Iris, Fix, Oren, James, Laura P. · 2017 · Clinical Gastroenterology and Hepatology
Cited by 66

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND & AIMS A rapid and reliable point‐of‐care assay to detect acetaminophen protein adducts in the serum of patients with acute liver injury could improve diagnosis and management. AcetaSTAT is a competitive immunoassay used to measure acetaminophen protein adducts formed by toxic metabolites in serum samples from patients. We compared the accuracy of AcetaSTAT vs high‐pressure liquid chromatography with electrochemical detection (HPLC‐EC; a sensitive and specific quantitative analytic assay) to detect acetaminophen protein adducts. METHODS We collected serum samples from 19 healthy individuals (no liver injury, no recent acetaminophen use), 29 patients without acetaminophen‐associated acute liver injury, and 33 patients with acetaminophen‐associated acute liver injury participating in the Acute Liver Failure Study Group registry. Each serum sample was analyzed by AcetaSTAT (reported as test band amplitude) and HPLC‐EC (the reference standard). We also collected data on patient age, sex, weight, level of alanine aminotransferase on test day and peak values, concentration of acetaminophen, diagnoses (by site investigator and causality review committee), and outcome after 21 days. Differences between groups were analyzed using the Fisher exact test for categoric variables and the Kruskal–Wallis test or rank‐sum test for continuous variables. RESULTS AcetaSTAT discriminated between patients with and without acetaminophen‐associated acute liver injury; the median AcetaSTAT test band amplitude for patients with acetaminophen‐associated acute liver injury was 584 (range, 222–1027) vs 3678 (range, 394–8289) for those without (P < .001). AcetaSTAT identified patients with acetaminophen‐associated acute liver injury with 100% sensitivity, 86.2% specificity, a positive predictive value of 89.2%, and a negative predictive value of 100%. Results from AcetaSTAT were positive in 4 subjects who received a causality review committee diagnosis of non–acetaminophen‐associated acute liver injury; HPLC‐EC and biochemical profiles were consistent with acetaminophen‐associated acute liver injury in 3 of these cases. CONCLUSIONS The competitive immunoassay AcetaSTAT shows a high degree of concordance with HPLC‐EC results in identifying patients with acetaminophen‐associated acute liver injury. This rapid and simple assay could increase early detection of this disorder and aid clinical management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2016.09.007

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Roberts, D. W., Lee, W. M., Hinson, J. A., Bai, S., Swearingen, C. J., Stravitz, R. T., Reuben, A., Letzig, L., Simpson, P. M., Rule, J., Fontana, R. J., Ganger, D., Reddy, K. R., Liou, I., Fix, O., & James, L. P.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2017-04
Volume
15
Issue
4
Pages
555-562.e3
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2519450735
Cited by
66
References
5
FWCI
11.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.